Viral hepatocarcinogenesis: from infection to cancer. - Test2 - elhamkhani - TriplyDB

Viral hepatocarcinogenesis: from infection to cancer.

Viral hepatocarcinogenesis: from infection to cancer.

http://www.wikidata.org/entity/Q34587991

about

The history of tumor virology Hepatocellular carcinoma mouse models: Hepatitis B virus-associated hepatocarcinogenesis and haploinsufficient tumor suppressor genes Smad3 phospho-isoform signaling in hepatitis C virus-related chronic liver diseases Hepatitis C virus targets over-expression of arginase I in hepatocarcinogenesis Association between hepatitis C and hepatocellular carcinoma Therapy and prognostic features of primary clear cell carcinoma of the liver Recurrence patterns and prognostic factors in patients with hepatocellular carcinoma in noncirrhotic liver: a multi-institutional analysis.Efficient inhibition of hepatitis B virus replication by hepatitis delta virus ribozymes delivered by targeting retrovirus.View and review on viral oncology research.On-site Basic Health Screening and Brief Health Counseling of Chronic Medical Conditions for Veterans in Methadone Maintenance Treatment The emerging role of hepatitis B virus pre-S2 deletion mutant proteins in HBV tumorigenesis.Inflammatory response of endothelial cells to hepatitis C virus recombinant envelope glycoprotein 2 protein exposure.Multiple pregnancies, hepatitis C, and risk for hepatocellular carcinoma in Egyptian women Uracil DNA glycosylase counteracts APOBEC3G-induced hypermutation of hepatitis B viral genomes: excision repair of covalently closed circular DNA.Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression.Hepatocellular carcinoma in Asia: Prevention strategy and planning.The attenuated hepatocellular carcinoma-specific Listeria vaccine Lmdd-MPFG prevents tumor occurrence through immune regulation of dendritic cells Vitamin D Status and Virologic Response to HCV Therapy in the HALT-C and VIRAHEP-C Trials.Acetaminophen-induced acute liver injury in HCV transgenic mice.IL-28B polymorphisms and treatment response in hepatitis C virus patients with persistently normal alanine aminotransferase.Chemoprevention and novel therapy for hepatocellular carcinoma associated with chronic hepatitis B virus infection.Viral-induced human carcinogenesis: an oxidative stress perspective.The epithelial cell and lung cancer: the link between chronic obstructive pulmonary disease and lung cancer.The ambiguity in immunology.Hepatitis viruses exploitation of host DNA methyltransferases functions.Telomerase-specific oncolytic adenoviral therapy for orthotopic hepatocellular carcinoma in HBx transgenic mice.Genetic variation in PTX3 and plasma levels associated with hepatocellular carcinoma in patients with HCV.Alcoholism worsens the survival of patients with hepatitis B virus and C virus-related hepatocellular carcinoma.Risk Factors for Intrahepatic Recurrence after Resection of Hepatocellular Carcinomas in Patients with Hepatitis B Virus Infection Outcomes after curative hepatectomy in patients with non-B non-C hepatocellular carcinoma and hepatitis B virus hepatocellular carcinoma from non-cirrhotic liver.Elevated p53 promotes the processing of miR-18a to decrease estrogen receptor-α in female hepatocellular carcinoma.Promotion of hepatocellular carcinoma by hepatitis C virus.PTEN in liver diseases and cancer Hepatitis C Virus nonstructural 5A protein inhibits lipopolysaccharide-mediated apoptosis of hepatocytes by decreasing expression of Toll-like receptor 4.E2F-1 is overexpressed and pro-apoptotic in human hepatocellular carcinoma.A comparison of prognosis between patients with hepatitis B and C virus-related hepatocellular carcinoma undergoing resection surgery.Histone deacetylase inhibitor suberoylanilide hydroxamic acid suppresses the pro-oncogenic effects induced by hepatitis B virus pre-S2 mutant oncoprotein and represents a potential chemopreventive agent in high-risk chronic HBV patients.Vitamins B status and antioxidative defense in patients with chronic hepatitis B or hepatitis C virus infection.HBx-mediated miR-21 upregulation represses tumor-suppressor function of PDCD4 in hepatocellular carcinoma.Cancer risk in patients with pyogenic liver abscess: a nationwide cohort study.

P2860

Q24610004-79CBAB2D-88AE-4874-8949-23E51D371F87 Q26772317-61FAF03D-03F0-4DAF-9401-06D66F36E7F4 Q26863522-F775755B-27DA-4B77-A9BE-C5D382A45B6D Q27488846-579AD72D-E2A6-4D9D-8D6D-D5EB624988CE Q27491295-C564248D-B68D-4A6B-8598-44BD7F5312B8 Q33632378-95DB0EF7-17E9-41B0-9F02-EC84BB710094 Q33720753-89F90667-13D8-41CF-B69A-BF8A28ABA033 Q33774434-B7C9C299-F712-40AF-A839-208C08A44D69 Q33894872-559E2AE4-3186-4410-9DC8-E6BEECF8B25D Q34093399-83827897-EF15-4A90-B023-7ED586417996 Q34354947-BC1ADC12-A97B-4BF2-82FB-15EDBEE902D2 Q34548428-8215B844-492F-476A-BDB8-A1F413C26F38 Q34649405-123905AB-9593-489D-A5EF-1020DB7FF18F Q34733579-FA158695-438E-44A5-9B85-0581AC65A381 Q34983256-20F29D7D-3B56-4E7E-908B-0BB0734410FE Q35790424-ED9C9933-1F9F-4391-B01F-D10B438E0CD1 Q35832233-C1D08D1C-BAB9-4463-9468-9464DB444422 Q36188710-9B33FB7D-E619-474B-8567-6646BE035D76 Q36501177-D3253B08-BEFB-41AF-9AE7-00BBFFB1FB5A Q37358287-936F1AE1-080D-45AF-97A8-CEE83088EC10 Q37584585-2A1CAE39-C0CF-4FFA-81DD-86F02128FB37 Q37740995-86B09B29-E555-4180-93D2-A69EE689A3D2 Q37839576-954814BB-D5DF-47AA-85F9-78AF454BA360 Q38008353-B96F0641-F311-4CA2-96BA-72877E820767 Q38543225-CB50B029-AE49-4AF1-847E-1C7FFAB7E17A Q39298850-45A48A71-AC9C-4DD4-AE65-20765E7B1462 Q40509021-B48FFC3D-E677-4072-BAD0-53978212EDDD Q40707188-6B8095AC-8E1E-4AD8-B10A-45E4A563ADEA Q41862329-AE558596-28BB-4F36-8B0D-0EE5214CF760 Q42196212-63490F79-28F1-4E00-ADD8-0098084015F9 Q42209351-2FED2AD5-982C-4731-9EFF-0371E00AEE65 Q42288500-7C283EBA-71F2-49A6-A30B-5EF3FFCF501A Q42412809-1BEC60CB-542E-4007-AE53-A0A4031602A1 Q43039732-121EAF67-E1AE-46B5-BB2D-AADB4ADDD3E6 Q43537069-ABC060A9-119A-4C1F-82D2-12EBEB0F858E Q45166388-7C1ED562-A5EC-412F-BF85-5142E7F54522 Q45203862-542A310F-A539-45DC-9EB4-10C0F3AE1AEB Q45370240-A2195610-9E8A-4F61-97E8-F3E95EB52589 Q46669089-FCBB7A1D-DA76-4F1C-8B73-79C2CBC11E28 Q48647444-F2CE7151-0105-4F8A-9B06-F1642CB05C91

P2860

Viral hepatocarcinogenesis: from infection to cancer.

http://www.wikidata.org/entity/Q34587991

description

2008 nî lūn-bûn

@nan

2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Viral hepatocarcinogenesis: from infection to cancer.

@ast

Viral hepatocarcinogenesis: from infection to cancer.

@en

Viral hepatocarcinogenesis: from infection to cancer.

@nl

type

label

Viral hepatocarcinogenesis: from infection to cancer.

@ast

Viral hepatocarcinogenesis: from infection to cancer.

@en

Viral hepatocarcinogenesis: from infection to cancer.

@nl

prefLabel

Viral hepatocarcinogenesis: from infection to cancer.

@ast

Viral hepatocarcinogenesis: from infection to cancer.

@en

Viral hepatocarcinogenesis: from infection to cancer.

@nl

P1433

Q34587991-4D4DE1AE-52A4-4118-8862-75C518D36335

P1476

Q34587991-C2382EA2-0FA4-4F23-AE50-845BC0325446

P2093

Q34587991-304ECBFC-E71A-4BAE-BAED-BAC9421F2FA6

Q34587991-37D4ECE2-CD63-458E-B1B2-2A32F774BBED

Q34587991-890CBDF3-D94D-4536-B76E-891A11A75604

Q34587991-B1C72996-C6F1-46CE-ABBF-D469ADA93745

Q34587991-E0C4C5AC-C975-4C6F-B0E4-2160F066518C

P2860

Q34587991-13198BAC-8CF5-486D-AF5C-8559810E38A1

Q34587991-3245D3C3-E855-4E73-AAA2-15414ECC6D72

Q34587991-8FAA9099-F509-42B2-A47F-4F5D34BA5AD6

Q34587991-93598C77-DD86-4E6F-95A4-D5D5932A7C9A

Q34587991-A7DE8D7A-0C98-486B-9AAD-A4156BC402FB

Q34587991-B3C3C686-86D1-4960-9C36-8148F4975273

Q34587991-BEAF2064-2D1B-414D-8819-250820AFC0D0

Q34587991-F82AE157-8FDD-4609-AD25-9A1335DE5344

P304

Q34587991-931ED9F0-9C4F-4CE5-80DB-FBEF628E32F9

P31

Q34587991-DA63FBFE-79F2-41A2-9A1A-69E1D67CB989

P356

Q34587991-674A1CAB-808A-4000-9237-5F0C538E7F48

P433

Q34587991-9D81B53E-E17F-46DE-B0D5-64CB261983F6

P478

Q34587991-A24E1E23-BFED-4558-9135-4A3168FC80D9

P577

Q34587991-14B9FCE1-63AC-4926-A987-263F9076908D

P5875

Q34587991-7F97FD2A-87CA-436C-AC95-50AE33A64805

P698

Q34587991-F77856F4-D8BD-4459-AFE2-6328338C55EA

P356

J.1478-3231.2007.01652.X

P1433

Liver International

P1476

Viral hepatocarcinogenesis: from infection to cancer.

@en

P2093

Alexander Tan

http://www.w3.org/2001/XMLSchema#string

Chun-Jen Liu

http://www.w3.org/2001/XMLSchema#string

Claudia Cheung

http://www.w3.org/2001/XMLSchema#string

Pei-Jer Chen

http://www.w3.org/2001/XMLSchema#string

Shiou-Hwie Yeh

http://www.w3.org/2001/XMLSchema#string

P2860

Aberrant Promoter Methylation Profiles of Tumor Suppressor Genes in Hepatocellular Carcinoma

Hepatitis C virus NS5A protein binds TBP and p53, inhibiting their DNA binding and p53 interactions with TBP and ERCC3

A practical approach to managing patients with HCV infection.

Beta-catenin mutations are frequent in human hepatocellular carcinomas associated with hepatitis C virus infection.

p53-dependent transcriptional repression of p21(waf1) by hepatitis C virus NS3.

Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy.

Expression of hepatitis B virus X oncoprotein inhibits transcription-coupled nucleotide excision repair in human cells.

Entecavir for Treatment of Lamivudine-Refractory, HBeAg-Positive Chronic Hepatitis B

P304

175-188

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1478-3231.2007.01652.X

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2008-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5600260

http://www.w3.org/2001/XMLSchema#string

P698

18251977

http://www.w3.org/2001/XMLSchema#string